Skip to content
HowShorted

Acorda Therapeutics, Inc. short interest in 2022

In 2022, Acorda Therapeutics, Inc.'s disclosed short interest ran from 1.46% of shares outstanding on 15 Mar 2022 to 1.80% on 30 Dec 2022, a change of +0.34 percentage points. The year's high was 3.27% on 15 Nov 2022 and its low 0.64% on 29 Apr 2022, averaging 1.42% across 13 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.61 days on 14 Apr 2022. Full history: Acorda Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for Acorda Therapeutics, Inc. in 2022

2022 in figures

Start of year
1.46% (15 Mar 2022)
End of year
1.80% (30 Dec 2022)
Change
+0.34 pp
High
3.27% (15 Nov 2022)
Low
0.64% (29 Apr 2022)
Average
1.42%
Highest days to cover
3.61 (14 Apr 2022)
SEC filings marked
8

Every report in 2022

Acorda Therapeutics, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
15 Mar 20221.46%2.35results (8-K)
31 Mar 20221.08%2.5410-K filed
14 Apr 20220.89%3.61
29 Apr 20220.64%1.83
29 Jul 20221.60%1.13results (8-K), 10-Q filed
15 Aug 20220.67%1.00results (8-K), 10-Q filed
31 Aug 20220.97%1.12
15 Sep 20220.91%1.59
30 Sep 20220.99%1.00
15 Nov 20223.27%1.00results (8-K), 10-Q filed
30 Nov 20222.27%3.42
15 Dec 20221.96%3.32
30 Dec 20221.80%1.77

See also: Acorda Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.